Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors

doi:10.3748/wjg.v30.i11.1533

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3210)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-7) series.

Item

Count

PDF

111

HTML

1745

Figures (1-2)

301

Tables (1-7)

298

Sum=2455

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

110

Download

535

Sum=645

Mar 21, 2024 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Mar 21, 2024; 30(11): 1533-1544
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1533

Table 7 Logistic multivariate regression analysis of poor prognosis in patients with liver cancer complicated with portal hypertension

Item	β	SE	Wald	P value	Exp (B)	95%CI
High Child-Pugh grade	1.470	0.738	3.970	0.046	4.349	1.024-18.469
History of hepatitis	2.286	0.803	8.098	0.004	9.833	2.037-47.463
Tumor size (6-10 cm)	2.399	0.788	9.268	0.002	11.008	2.350-51.567
No use of sorafenib	2.483	0.829	8.963	0.003	11.981	2.357-60.884
Liver cancer of stage IIIC	1.900	0.719	6.988	0.008	6.683	1.634-27.329
Previous splenectomy	1.629	0.741	4.835	0.028	5.101	1.194-21.800
Constant	6.685	1.486	20.226	< 0.001	0.001

Citation: Yang LM, Wang HJ, Li SL, Gan GH, Deng WW, Chang YS, Zhang LF. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors. World J Gastroenterol 2024; 30(11): 1533-1544
URL: https://www.wjgnet.com/1007-9327/full/v30/i11/1533.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i11.1533